Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02227290 · ClinicalTrials.gov registry record · Phase 4
Pediatric Subjects With Tinea Corporis
A Phase 4 study of Tinea Corporis, sponsored by Merz North America.
- Completed
- Registry status
- Phase 4
- Development phase
- 230
- Enrollment target
- 19
- Study locations
NCT02227290 is a Phase 4 study of Tinea Corporis that has completed, run by Merz North America. The registered enrollment target is 230 participants. The trial reports 19 study locations across 10 states.
The verdict
NCT02227290, a Phase 4 study of Tinea Corporis, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 230 participants
- Enrollment target
- 19
- Study locations
Study Summary
The study is being done to see how well the study cream works when applied once a day to affected area of child (where they have ringworm). The results will be compared to those seen with a placebo cream which has no active ingredient. Safety of the cream will also be measured.
Conditions Studied
Interventions
- DRUG Naftin Cream
- DRUG Placebo Cream
Study Locations (19)
Other
- Merz Investigative Site#180002 - San Cristóbal
- Merz Investigative Site# 180001 - Santo Domingo
- Merz Investigative Site#504001 - San Pedro Sula
- Merz Investigative Site#507001 - Panama City
- Merz Investigative Site#001279 - Cidra
California
- Investigative Site# 0010320 - Encino
- Merz Investigative Site#001313 - Fremont
- Merz Investigative Site#001301 - San Diego
Florida
- Merz Investigative Site#001312 - Miami
- Merz Investigative Site#001311 - Miami
- Merz Investigative Site #001310 - Miramar
North Carolina
- Merz Investigative Site#001126 - Raleigh
- Merz Investigative Site#001293 - Winston-Salem
Arizona
- Merz Investigative Site#001316 - Tucson
Missouri
- Merz Investigative Site#001307 - Saint Joseph
Nebraska
- Merz Investigative Site#001309 - Omaha
Nevada
- Merz Investigative Site#001314 - Henderson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02227290
The ClinicalTrials.gov registry entry for NCT02227290 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tinea Corporis appearing as the primary indexed condition, and to 2 interventions - of which Naftin Cream is the first listed.
NCT02227290 reports 19 study locations spanning 10 distinct geographic areas - top geographies include Other, California, Florida.
Frequently Asked Questions
What is clinical trial NCT02227290 about?
NCT02227290 is a clinical study titled "Pediatric Subjects With Tinea Corporis". The study is being done to see how well the study cream works when applied once a day to affected area of child (where they have ringworm). The results will be compared to those seen with a placebo cream which has no active ingredient. Safety of the cream will also be measured.
What is the current status of trial NCT02227290?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 230 participants. The study started on 2014-08. Estimated completion is 2015-12.
What conditions does trial NCT02227290 study?
This clinical trial studies the following conditions: Tinea Corporis.
What interventions are being tested in trial NCT02227290?
The interventions under investigation include: Naftin Cream (DRUG), Placebo Cream (DRUG).
Who is sponsoring clinical trial NCT02227290?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02227290 being conducted?
This trial has 19 study locations across Arizona, California, Florida, Missouri, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinea Corporis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.